Cognition Therapeutics, Inc.
corporate_fare Company Profile
Cognition Therapeutics, Inc. (NASDAQ:CGTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for CGTX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Cognition Therapeutics Completes Productive FDA Type C Meeting for Zervimesine in Dementia with Lewy Bodies
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$23.49M
Diluted EPS
-$0.32
Op. Cash Flow
-$24.59M
Operating Income
-$47.8M
Cash & Equivalents
$36.81M
Debt / Equity
0.00×
Shares Outstanding
88.9M sh
Source: 10-K · filed 2026-03-26 · accession 0001104659-26-034880
show_chartPrice Chart
Loading chart...
feed CGTX - Filings & News (Page 2)
CGTX
Jan 27, 2026, 7:37 AM EST
Price at Filing:
$1.40
Real-time Price:
$0.580
Change:
-$0.820 (-59%)
Market Cap:
$55.368M